Literature DB >> 15777490

A pilot study of regional participation in a videoconferenced multidisciplinary genitourinary tumor board.

Glenn Bauman1, Eric Winquist, Joseph Chin.   

Abstract

A successful pilot study of a videoconferenced multidisciplinary genitourinary tumor board involving 21 physicians over six geographic sites for a 6-month period is reported. The majority of cases presented at the tumor board were of prostate or bladder origin. Specific recommendations around management, patient referral or clinical trial eligibility were made in the majority of cases presented. Physician satisfaction with the rounds was high and participation beyond the pilot has continued. Scheduling in order to provide maximum access/participation has been the main logistical challenge with the rounds.

Entities:  

Mesh:

Year:  2005        PMID: 15777490

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  4 in total

1.  Urologists and radiation oncologists: working together for patient care.

Authors:  Joseph Chin
Journal:  Can Urol Assoc J       Date:  2008-06       Impact factor: 1.862

2.  Evaluating the impact of the genitourinary multidisciplinary tumour board: Should every cancer patient be discussed as standard of care?

Authors:  Kyle Scarberry; Lee Ponsky; Edward Cherullo; William Larchian; Donald Bodner; Matthew Cooney; Rodney Ellis; Gregory Maclennan; Ben Johnson; William Tabayoyong; Robert Abouassaly
Journal:  Can Urol Assoc J       Date:  2018-05-14       Impact factor: 1.862

3.  Development of a virtual multidisciplinary lung cancer tumor board in a community setting.

Authors:  Marvaretta M Stevenson; Tonia Irwin; Terry Lowry; Maleka Z Ahmed; Thomas L Walden; Melanie Watson; Linda Sutton
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

Review 4.  Benefits and drawbacks of videoconferencing for collaborating multidisciplinary teams in regional oncology networks: a scoping review.

Authors:  Lidia S van Huizen; Pieter U Dijkstra; Sjoukje van der Werf; Kees Ahaus; Jan Ln Roodenburg
Journal:  BMJ Open       Date:  2021-12-09       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.